A physician scientist is making strides in understanding the molecular origins of fatty liver disease, a leading cause of liver failure in the United States. An Indiana University School of Medicine ...

Pain crises are a primary feature of sickle cell disease, triggering pain when crescent-shaped blood cells block the flow of oxygen to tissues. Now, a new study finds that these crises may be ...

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries. The ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Google DeepMind’s research team recently published in the international academic journal *Nature* the development process of ...

Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025 Provided by PR Newswire Jul 31, 2025, 6:00:00 AM Neurophet Showcases ...